For in vivo, injection of GDF11‐overexpressing MSCs had better cell retention, and resulted in better cardiac function, angiogenesis and decreased cardiac fibrosis in a mouse MI model (Figure 7). The gene discussed is GDF11; the disease is myocardial infarction.